What is MASLD?

MASLD is a common condition where fat builds up in the liver. It is often linked to being overweight and conditions like type 2 diabetes and heart disease.

 

The information on this page is for:

  • Adults with MASLD or at risk of MASLD.
  • Family, friends, carers, and healthcare professionals.

MASLD can also affect children and young people. See our information for parents and families.

On this page:

What is MASLD?

 

Metabolic dysfunction-associated steatotic liver disease (MASLD) happens when too much fat builds up in the liver. It is a long-term (chronic) liver disease, which means it develops slowly and may get worse over time.

MASLD is often linked to conditions like obesity, type 2 diabetes and heart disease. These are sometimes called metabolic conditions.

The liver is a large organ found at the top of the abdomen on the right side. It is made up of cells (hepatocytes), blood vessels and bile ducts. The liver has around 500 different jobs.

Find out more about the liver

Your liver is not meant to store extra fat. When fat builds up in the liver, it can cause inflammation (irritation and swelling). Over time, this damages liver cells. In some people, it can progress to a more serious stage where scarring (fibrosis) builds up in the liver. In a small number of people, it can lead to cirrhosis, liver failure or liver cancer.

How common is MASLD?

 

MASLD is very common. About 1 in 4 adults in the UK have it. It is also the biggest cause of long-term (chronic) liver disease worldwide.

MASLD can affect anyone, including children. But it becomes more common as people get older. Genetics and ethnic background matter too, with more people of Asian descent being affected. MASLD is also more common in men.

The number of people in the UK with MASLD is increasing. This rise is linked to rising rates of overweight and obesity. About 1 in 20 adults may have more advanced liver scarring.

 

What are the different names for MASLD?

 

MASLD, NAFLD and fatty liver disease are different names for the same condition.

In 2023, an international group of healthcare professionals and patients updated the names for the condition.

 

Old term New term
Non-alcohol related fatty liver disease (NAFLD) Metabolic dysfunction-associated steatotic liver disease

 

If you have more advanced liver disease, you may also hear the term metabolic dysfunction-associated steatohepatitis (MASH). This was previously called non-alcohol related steatohepatitis (NASH). This is simply another way that doctors may refer to more advanced liver scarring.

The new terms aim to:

  • better reflect the complexity of the condition
  • show that metabolism plays a key role
  • avoid terms such as “non-alcoholic” and “fatty”, which some people may find upsetting or judgemental

You might still hear and see both the old and new terms for a while. But knowing the different terms can help make conversations clearer. You can use whichever name you feel most comfortable with. In our information, we use the new terms to help keep things simple.

What do the different terms mean?

 

The name MASLD stands for metabolic dysfunction-associated steatotic liver disease. See the table below to understand what the different words mean.

 

Term Meaning
Metabolic connected with how your body uses and stores energy from food

Dysfunction

when something isn’t working properly or has gone wrong

Associated

linked to or caused by

Steatotic

fatty

 

So, in simpler terms, MASLD means fatty liver disease caused by something going wrong with how the body uses and stores energy.

Remember: If you are unsure about terms or medical words it is always ok to ask questions.

How we can help

Support for you

We’re here to support anyone affected by liver disease, as well as their families and loved ones.

Your feedback

This content was last reviewed: July 2026

Our expert reviewers:

We would like to thank everyone who helped with creating and reviewing this page. Including Dr Jeremy Cobbold, Consultant Hepatologist, Oxford University Hospitals, Professor Stuart McPherson, Consultant Hepatologist, Newcastle upon Tyne Hospitals and Dr Helen Jarvis, GP, Newcastle University. And all our patient reviewers.

Find out how we make our patient information.

Everyone’s experience of liver disease will be different. Always talk to your specialist medical team for personal advice.

More from Liver UK

Check your risk

Check your risk

Find out if you’re at risk of liver disease using our simple at-risk checker for adults.

Find out more

Support us

Support us

Make a donation to help ensure everyone affected by liver disease gets the information and support they need.

Find out more

Keep up to date

Keep up to date

Keep up to date with the charity’s news by registering for our email newsletter & updates.

Find out more

No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.